Treatment-resistant Schizophrenia

• FDA approval · 2021-07-29
  FDA Approved: CLOZAPINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved a supplemental application for CLOZAPINE submitted by Teva Pharmaceuticals USA, Inc.

• FDA approval · 2019-01-16
  FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

  FDA approved a supplemental application to authorize a generic version of Clozapine manufactured by Mylan Pharmaceuticals Inc.

• FDA approval · 2017-02-23
  FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)

  The FDA approved a supplemental application for Clozaril (clozapine) submitted by HLS Therapeutics (USA), Inc., resulting in changes to its …

• FDA approval · 2015-09-18
  FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)

  FDA approved a supplemental application for CLOZARIL (clozapine) submitted by HLS Therapeutics (USA), Inc., signaling an update to the produ…

• FDA approval · 2014-03-25
  FDA Approved: VERSACLOZ — Supplemental Application (TruPharma LLC)

  FDA approved a supplemental application for VERSACLOZ (clozapine) from TruPharma LLC, updating the labeling per the supplemental filing.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.